Biological functions
| Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
|---|---|---|---|---|---|---|---|---|---|---|
| BP | GO:0070588 | calcium ion transmembrane transport | 45/1647 | 315/18670 | 0.0008652 | 0.004705 | 0.002844 | 45 | RABC9 | |
| BP | GO:0040013 | negative regulation of locomotion | 54/1647 | 396/18670 | 0.0008657 | 0.004705 | 0.002844 | 54 | RABC9 | |
| BP | GO:1904062 | regulation of cation transmembrane transport | 48/1647 | 342/18670 | 0.0008783 | 0.004769 | 0.002883 | 48 | RABC9 | |
| BP | GO:0090130 | tissue migration | 50/1647 | 360/18670 | 0.0008792 | 0.004769 | 0.002883 | 50 | RABC9 | |
| BP | GO:0002686 | negative regulation of leukocyte migration | 12/1647 | 49/18670 | 0.0009001 | 0.004866 | 0.002941 | 12 | RABC9 | |
| BP | GO:0002704 | negative regulation of leukocyte mediated immunity | 12/1647 | 49/18670 | 0.0009001 | 0.004866 | 0.002941 | 12 | RABC9 | |
| BP | GO:0045010 | actin nucleation | 12/1647 | 49/18670 | 0.0009001 | 0.004866 | 0.002941 | 12 | RABC9 | |
| BP | GO:1990090 | cellular response to nerve growth factor stimulus | 12/1647 | 49/18670 | 0.0009001 | 0.004866 | 0.002941 | 12 | RABC9 | |
| BP | GO:0050821 | protein stabilization | 29/1647 | 178/18670 | 0.0009099 | 0.004914 | 0.002971 | 29 | RABC9 | |
| BP | GO:0001660 | fever generation | 5/1647 | 10/18670 | 0.0009166 | 0.004928 | 0.002979 | 5 | RABC9 | |
| BP | GO:0048340 | paraxial mesoderm morphogenesis | 5/1647 | 10/18670 | 0.0009166 | 0.004928 | 0.002979 | 5 | RABC9 | |
| BP | GO:0060068 | vagina development | 5/1647 | 10/18670 | 0.0009166 | 0.004928 | 0.002979 | 5 | RABC9 | |
| BP | GO:0072015 | glomerular visceral epithelial cell development | 5/1647 | 10/18670 | 0.0009166 | 0.004928 | 0.002979 | 5 | RABC9 | |
| BP | GO:2000271 | positive regulation of fibroblast apoptotic process | 5/1647 | 10/18670 | 0.0009166 | 0.004928 | 0.002979 | 5 | RABC9 | |
| BP | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 17/1647 | 84/18670 | 0.0009283 | 0.004978 | 0.003009 | 17 | RABC9 | |
| BP | GO:0050818 | regulation of coagulation | 17/1647 | 84/18670 | 0.0009283 | 0.004978 | 0.003009 | 17 | RABC9 | |
| BP | GO:0097756 | negative regulation of blood vessel diameter | 17/1647 | 84/18670 | 0.0009283 | 0.004978 | 0.003009 | 17 | RABC9 | |
| BP | GO:0006022 | aminoglycan metabolic process | 28/1647 | 170/18670 | 0.00093 | 0.004983 | 0.003012 | 28 | RABC9 | |
| BP | GO:0043500 | muscle adaptation | 22/1647 | 122/18670 | 0.0009423 | 0.005044 | 0.003049 | 22 | RABC9 | |
| BP | GO:0045834 | positive regulation of lipid metabolic process | 25/1647 | 146/18670 | 0.0009651 | 0.005158 | 0.003118 | 25 | RABC9 | |
| BP | GO:0009308 | amine metabolic process | 24/1647 | 138/18670 | 0.0009653 | 0.005158 | 0.003118 | 24 | RABC9 | |
| BP | GO:0030258 | lipid modification | 36/1647 | 238/18670 | 0.000981 | 0.005237 | 0.003165 | 36 | RABC9 | |
| BP | GO:0031330 | negative regulation of cellular catabolic process | 39/1647 | 264/18670 | 0.0009817 | 0.005237 | 0.003165 | 39 | RABC9 | |
| BP | GO:0002637 | regulation of immunoglobulin production | 14/1647 | 63/18670 | 0.0009859 | 0.005244 | 0.00317 | 14 | RABC9 | |
| BP | GO:0046637 | regulation of alpha-beta T cell differentiation | 14/1647 | 63/18670 | 0.0009859 | 0.005244 | 0.00317 | 14 | RABC9 | |
| BP | GO:0090181 | regulation of cholesterol metabolic process | 14/1647 | 63/18670 | 0.0009859 | 0.005244 | 0.00317 | 14 | RABC9 | |
| BP | GO:0010863 | positive regulation of phospholipase C activity | 11/1647 | 43/18670 | 0.0009891 | 0.005244 | 0.00317 | 11 | RABC9 | |
| BP | GO:0045429 | positive regulation of nitric oxide biosynthetic process | 11/1647 | 43/18670 | 0.0009891 | 0.005244 | 0.00317 | 11 | RABC9 | |
| BP | GO:0050850 | positive regulation of calcium-mediated signaling | 11/1647 | 43/18670 | 0.0009891 | 0.005244 | 0.00317 | 11 | RABC9 | |
| BP | GO:0051602 | response to electrical stimulus | 11/1647 | 43/18670 | 0.0009891 | 0.005244 | 0.00317 | 11 | RABC9 |